Insider · CIK 0001656506
Steven Hyman
Files at VYGR (Voyager Therapeutics, Inc.), KRSA (Cyclerion Therapeutics, Inc.). First filing -, latest -.
In brief
Steven Hyman files SEC Form 4 as director at VYGR (Voyager Therapeutics, Inc.), and also at KRSA (Cyclerion Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven Hyman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | VYGR Voyager Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | - | Jun 11, 2026 |
| Jun 3, 2025 | VYGR Voyager Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +24,000 | $0.00 | $0 | 24,000 | Jun 4, 2025 |
| Jun 5, 2024 | VYGR Voyager Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +24,000 | $0.00 | $0 | 24,000 | Jun 7, 2024 |
| Nov 30, 2023 | KRSA Cyclerion Therapeutics, Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 20,000 | Dec 4, 2023 |
Questions about Steven Hyman
Answered from the filings on this page, as of the latest one.
Is Steven Hyman buying or selling?
Steven Hyman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven Hyman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven Hyman has 0.
Where does Steven Hyman file Form 4?
Steven Hyman has filed Form 4 at VYGR (Voyager Therapeutics, Inc.); KRSA (Cyclerion Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.